Emmaus Life Sciences (EMMA)
(Delayed Data from OTC)
$0.10 USD
0.00 (0.00%)
Updated Apr 26, 2024 12:53 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
EMMA 0.10 0.00(0.00%)
Will EMMA be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for EMMA based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for EMMA
Emmaus Life Sciences Reports Delayed Filing of Annual Report
Great Elm Group And 2 Other Stocks Under $2 Insiders Are Buying
Emmaus Life Sciences Inc Annual Shareholders Meeting Transcript
Emmaus Life Sciences Inc at OTC Markets Life Sciences Virtual Investor Forum Transcript
Emmaus Life Sciences Inc Annual Shareholders Meeting Transcript